TCL Archive National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs. April 22, 2005
TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011